Company intelligence / Profile preview
Cells for Cells
Santiago, Santiago Metropolitan Region, Chilec4c.cl ↗
- Ownership
- Private
- Employees
- ~100
- Development stage
- Phase 2
01
Overview
Cells for Cells has developed a diverse portfolio of cell therapies and tissue-engineered products targeting high-prevalence chronic diseases. The company claims leadership in regenerative medicine in its region, with more than 800 patients treated. It continues to expand its intellectual property portfolio through new biomedical product development that can be outlicensed or spun off as profitable ventures.
- Therapeutic areas
- Other
- Modalities
- Allogeneic Mesenchymal Stem Cells (MSCs)Exosome therapy (extracellular vesicles)Tissue engineering and biomaterials
- Industry
- Biotech
02
Drug pipeline
11 assets10 more assets in the full pipeline.
Beyond the preview
Go deeper on Cells for Cells.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cells for Cells.